Dr. Carmen  Calfa  Medical Oncologist image

Dr. Carmen Calfa Medical Oncologist

3700 Johnson St Memorial Health System/Breast Cancer Center
Hollywood FL 33021
954 656-6990
Medical School: Other - Unknown
Accepts Medicare: No
Participates In eRX: No
Participates In PQRS: No
Participates In EHR: No
License #: TRN004767
NPI: 1114138534
Taxonomy Codes:

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy


Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found


None Found


Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response. - Cancer research
NKG2D ligands link the innate and adapative immune response by activating the receptors expressed on effector cells of both the innate (NK) and adaptive immune systems (CD8(+) T cells). In this study, we explored the potential therapeutic utility of this intersection by fusing the murine NKG2D ligand Rae-1β to the 3' end of an anti-HER2 IgG3 antibody containing an intact Fc domain (anti-HER2 IgG3-Rae-1β), thereby targeting an NK cell activation signal to HER2+ breast tumor cells. The antitumor efficacy of this anti-HER2-Rae-1β fusion protein was examined in a mouse mammary tumor model engineered to express HER2 (EMT6-HER2 cells). We observed an enhanced cytotoxic response of NK effectors against EMT-HER2 cells in vitro. Mice implanted on one flank with EMT6-HER2 cells and contralaterally with control EMT6 cells exhibited rapid regression of EMT6-HER2 tumors but delayed regression of contralateral EMT6 tumors. IFNγ was implicated, given a lack of antitumor efficacy in IFNγ(-/-) mice. Depletion of either NK cells or CD8(+) T cells abrogated tumor growth inhibition, suggesting essential roles for each in the observed antitumor activity. Mice rejecting EMT6-HER2 tumors after anti-HER2-Rae-1β treatment showed markedly decreased tumor growth when rechallenged with EMT6-HER2 or EMT6 cells, whereas both EMT6 and EMT6-HER2 cells grew in control mice, indicating the development of an adaptive memory response. Our findings demonstrate that administration of an antibody-NKG2D ligand fusion protein can enhance innate and adaptive immune antitumor responses, also evoking additional nontargeted antigens to enhance the potential clinical utility of this approach.©2010 AACR.
Ocular involvement as the initial manifestation of T-cell chronic lymphocytic leukemia. - American journal of ophthalmology
To present a case of T-cell chronic lymphocytic leukemia (T-CLL) manifesting as an intraocular lymphoma.Interventional case report.We performed a vitreous biopsy in a 67-year-old woman who presented with blurred vision and vitreous cellular infiltration. Morphologic, immunohistochemical, flow cytometry, and molecular analysis by polymerase chain reaction of vitreous fluid, peripheral blood, bone marrow aspirate, and biopsy were performed.Cytofluorographic and molecular analysis of vitreous cells demonstrated a monoclonal T-cell population consistent with a T-cell intraocular lymphoma. Systemic evaluation established diagnosis of T-cell CLL.T-CLL is a rare disease with an aggressive clinical course. We present a case of T-cell intraocular lymphoma as the initial manifestation of an otherwise asymptomatic T-CLL.

Map & Directions

3700 Johnson St Memorial Health System/Breast Cancer Center Hollywood, FL 33021
View Directions In Google Maps

Nearby Doctors

3801 Hollywood Blvd Suite 250
Hollywood, FL 33021
954 618-8303
3220 Stirling Rd Suite 103
Hollywood, FL 33021
954 660-0404
3363 Sheridan St Suite #210
Hollywood, FL 33021
954 874-4100
4700 K Sheridan St
Hollywood, FL 33021
954 620-0040
5351 Sheridan St
Hollywood, FL 33021
954 638-8282
3501 Johnson St
Hollywood, FL 33021
954 872-2000
3501 Johnson St Memorial Regional Hospital Dept Critical Care
Hollywood, FL 33021
954 659-9976
3501 Johnson St
Hollywood, FL 33021
954 733-3793
1051 N 35Th Ave Ste 202
Hollywood, FL 33021
954 633-3535
4350 Sheridan St Suite 201D
Hollywood, FL 33021
954 810-0012